The veterinary pharmaceuticals firm Dechra has revealed growing sales across all its major brands and profits ahead of market forecasts for the full year to the end of June.
Group revenue to the end of June increased by 9.5% compared to 2011, from £389.2m to £426m. That figure is also ahead of market expectations of £420.2m. Dechra says 7.9% of this growth was organic whilst 1.8% was contributed by the acquisition of Dutch rival Eurovet. Currency movements had a negative impact of 0.2%.
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE
Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
-
How to earn over 4% on your cash… using a stocks and shares ISASavers worried about a potential cut to the cash ISA limit could shield their money from the taxman using a money market fund in a stocks and shares ISA. We explain how
-
Do you still have to file a tax return if you don’t owe any tax?Even if you do not owe the taxman any money, failure to complete and submit your tax return could result in a penalty costing you up to £1,600.
